Free Trial
NASDAQ:INMD

InMode (INMD) Stock Price, News & Analysis

InMode logo
$16.30 -1.68 (-9.34%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$15.77 -0.53 (-3.28%)
As of 07:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About InMode Stock (NASDAQ:INMD)

Key Stats

Today's Range
$15.97
$17.54
50-Day Range
$16.30
$19.40
52-Week Range
$14.87
$20.98
Volume
2.60 million shs
Average Volume
1.17 million shs
Market Capitalization
$1.13 billion
P/E Ratio
6.94
Dividend Yield
N/A
Price Target
$22.25
Consensus Rating
Hold

Company Overview

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Remove Ads

InMode Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

INMD MarketRank™: 

InMode scored higher than 51% of companies evaluated by MarketBeat, and ranked 506th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InMode has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    InMode has only been the subject of 2 research reports in the past 90 days.

  • Read more about InMode's stock forecast and price target.
  • Earnings Growth

    Earnings for InMode are expected to grow by 4.00% in the coming year, from $1.75 to $1.82 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InMode is 6.94, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.62.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InMode is 6.94, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.23.

  • Price to Book Value per Share Ratio

    InMode has a P/B Ratio of 1.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about InMode's valuation and earnings.
  • Percentage of Shares Shorted

    9.79% of the float of InMode has been sold short.
  • Short Interest Ratio / Days to Cover

    InMode has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in InMode has recently increased by 1.12%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    InMode does not currently pay a dividend.

  • Dividend Growth

    InMode does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.79% of the float of InMode has been sold short.
  • Short Interest Ratio / Days to Cover

    InMode has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in InMode has recently increased by 1.12%, indicating that investor sentiment is decreasing.
  • News Sentiment

    InMode has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for InMode this week, compared to 5 articles on an average week.
  • Search Interest

    Only 3 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -70% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InMode insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.92% of the stock of InMode is held by insiders.

  • Percentage Held by Institutions

    68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InMode's insider trading history.
Receive INMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter.

INMD Stock News Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
INMD Crosses Below Key Moving Average Level
InMode CEO responds to Doma Perpetual’s letters
See More Headlines

INMD Stock Analysis - Frequently Asked Questions

InMode's stock was trading at $16.70 at the beginning of 2025. Since then, INMD shares have decreased by 2.4% and is now trading at $16.30.
View the best growth stocks for 2025 here
.

InMode Ltd. (NASDAQ:INMD) posted its quarterly earnings data on Thursday, August, 1st. The healthcare company reported $0.34 EPS for the quarter, missing the consensus estimate of $0.38 by $0.04. The business's quarterly revenue was down 24.6% on a year-over-year basis.

Shares of InMode split before market open on Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly issued shares were distributed to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

InMode subsidiaries include Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..

InMode (INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/01/2024
Today
4/04/2025
Next Earnings (Estimated)
5/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:INMD
Fax
N/A
Employees
480
Year Founded
2008

Price Target and Rating

Average Stock Price Target
$22.25
High Stock Price Target
$29.00
Low Stock Price Target
$16.00
Potential Upside/Downside
+36.5%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
6.94
Forward P/E Ratio
9.31
P/E Growth
N/A
Net Income
$181.27 million
Pretax Margin
36.34%

Debt

Sales & Book Value

Annual Sales
$394.82 million
Cash Flow
$1.57 per share
Price / Cash Flow
10.40
Book Value
$10.12 per share
Price / Book
1.61

Miscellaneous

Free Float
64,746,000
Market Cap
$1.13 billion
Optionable
Optionable
Beta
2.08

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:INMD) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners